| Title | Preliminary Biomarker Data from a Phase 1/2 Study of Golidocitinib Demonstrates Targeting JAK/STAT Pathway to Treat Peripheral T-Cell Lymphoma |
| Authors | Song, Yuqin Kim, Won-Seog Yoon, Dok-Hyun Yang, Haiyan Cao, Junning Ji, Dongmei Koh, Youngil Jing, Hongmei Eom, Hyeon-Seok Kwak, Jae-Yong Lee, Won-Sik Lee, Jong-Seok Shin, Ho-Jin Jin, Jie Wang, Mei Li, Jingrun Zhu, Jun |
| Affiliation | Peking Univ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China Samsung Med Ctr, Dept Med, Hematol & Oncol, Seoul, South Korea Asan Med Ctr, Hematol Canc & BMT Ctr, Dept Oncol, Seoul, South Korea Zhejiang Canc Hosp, Dept Lymphoma, Hangzhou, Peoples R China Fudan Univ, Dept Lymphoma, Shanghai Canc Ctr, Shanghai, Peoples R China Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Peking Univ, Dept Hematol, Hosp 3, Beijing, Peoples R China Ctr Hematol Malignancy, Natl Canc Ctr, Goyang, South Korea Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea Inje Univ, Dept Internal Med, Busan Paik Hosp, Busan, South Korea Seoul Natl Univ, Div Hematol & Med Oncol, Bundang Hosp, Seoul, South Korea Pusan Natl Univ, Med Res Inst, Dept Internal Med, Div Hematol Oncol,Sch Med, Busan, South Korea Zhejiang Univ, Sch Med, Dept Hematol, Affiliated Hosp 1, Hangzhou, Peoples R China Dizal Pharmaceut, Shanghai, Peoples R China |
| Issue Date | 15-Nov-2022 |
| Publisher | BLOOD |
| URI | http://hdl.handle.net/20.500.11897/670864 |
| ISSN | 0006-4971 |
| DOI | 10.1182/blood-2022-162947 |
| Indexed | CPCI-S(ISTP) SCI(E) |
| Appears in Collections: | 北京肿瘤医院 第三医院 |
